Treatment Comparisons: Finding What Actually Works

Published March 04, 2026 · 5 min read

By Tauri Urbanik, research writer and PainApp founder

Choosing a pain treatment shouldn't feel like guessing. But when you're overwhelmed and hurting, every option sounds either too good to be true or not good enough. Especially if you're just learning what neuroplastic pain actually is.

So we did the homework. Each comparison below puts two approaches side by side. Same format every time: what the research says, what it costs, how long it takes, and who it works best for. No spin. Just evidence. If you want to understand the treatment with the strongest clinical trial behind it, start with our guide to Pain Reprocessing Therapy.

Treatment approaches compared

Head-to-head comparisons of the major chronic pain treatment categories.

Neuroplastic Pain Treatments Compared

The complete overview. PRT, EAET, CBT, medication, and surgery compared in one place. Effectiveness, cost, time investment, and evidence level for each.

PRT vs CBT for Chronic Pain

Both are talk-based therapies. Both have evidence. But they work differently and produce different results. PRT targets the source of pain directly. CBT teaches coping. Here's what the trials show.

Medication vs Brain Retraining

Pain medication manages symptoms. Brain retraining addresses the source. One requires ongoing use with side effects. The other aims for lasting resolution. The evidence tells a clear story.

Back Surgery vs Conservative Treatment

Should you get back surgery? Sometimes yes. Often no. The research on when surgery helps, when it doesn't, and what the alternatives look like.

Digital tools and apps

Comparing digital options for chronic pain recovery.

Best Chronic Pain Apps 2026

Curable, PainApp, and other chronic pain apps reviewed. Features, pricing, evidence base, and real user experience compared side by side.

Curable vs PainApp

The two leading neuroplastic pain apps compared. Different approaches, different strengths. This breakdown helps you pick the right one for your situation.

Pain Apps vs In-Person Therapy

Can an app do what a therapist does? Sometimes. Research on digital pain interventions is growing. Here's when an app makes sense and when you need a real person. And if you're not sure whether your pain fits the neuroplastic profile, the neuroplastic pain assessment is a good place to start.

Frequently asked questions

What is the most effective treatment for chronic pain?

Research suggests brain-based treatments like Pain Reprocessing Therapy are the most effective for neuroplastic pain. The Boulder study found 33 of 50 people assigned to PRT were pain-free or nearly pain-free in 4 weeks. However, the best treatment depends on whether your pain is structural or neuroplastic.

How do pain apps compare to in-person therapy?

Pain apps offer accessibility and lower cost while in-person therapy provides personalized guidance. Research on digital interventions is growing, with early results showing comparable outcomes for many patients. The best choice depends on your situation and preferences.

Is brain retraining better than medication for chronic pain?

For neuroplastic pain, brain retraining addresses the root cause while medication manages symptoms. Research shows brain-based approaches produce lasting results without side effects. Medication can be helpful short-term, but alone it rarely resolves chronic pain long-term.

References

1. Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):13-23.DOI: 10.1001/jamapsychiatry.2021.2669
2. Lumley MA, Schubiner H, Lockhart NA, et al. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. PAIN. 2017;158(12):2354-2363.DOI: 10.1097/j.pain.0000000000001036
3. Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-S15.DOI: 10.1016/j.pain.2010.09.030